Duck Virus Enteritis Vaccine Market Size, Share, Growth and Trends Analysis By Type (Live Vaccines, Killed Vaccines), By Application (Duck, Others) and Regional Forecast to 2032

• 

   Request a Free Sample To Get More Information on this Market

DUCK VIRUS ENTERITIS VACCINE MARKET REPORT OVERVIEW

The global duck virus enteritis vaccine market size was USD 0.067 billion in 2023 and is expected to reach USD 0.108 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period from 2024 to 2032.

The creation of the vaccine was prompted by an urgent need to put a stop to the spread of duck plagues, an illness that has severely harmed many people's health and has the potential to increase the mortality rate among ducks and other affected animals and birds. Due to the growing commercial demand for poultry products, increased awareness of avian species disease prevention, and the important role that ducks play in the ecological system, the duck virus enteritis vaccines market share is on the path of expansion.

Further assisting factors in the market's growth are ongoing efforts in developing vaccine technology that provides much more safety and effectiveness from such diseases. To ensure that affected duck populations receive timely and effective vaccinations, pharmaceutical companies are also supporting research and development in this area.

COVID-19 IMPACT ON MARKET GROWTH RESTRAINED BY PANDEMIC DUE TO LOCKDOWN

The global COVID-19 pandemic has been unprecedented and staggering, with the Duck Virus Enteritis Vaccine market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

LATEST TRENDS

"Multipurpose Uses of Bivalent Vaccines"

An increasing emphasis on bivalent vaccinations is one of the recent developments in the duck virus enteritis vaccine market growth. Ducks that are injected with these highly efficient vaccines will gain full immunity against H5N1 avian influenza virus, and additionally many other similar types of virus immunity will also be fulfilled using the same vaccine.

DUCK VIRUS ENTERITIS VACCINE MARKET SEGMENTATION

By Type

• Live Vaccines-Live vaccines basically utilise a form of the virus which is still live in nature, but has been weakened significantly. These vaccines contain viruses which trigger the immune response system of ducks and other such waterfowl without causing them to develop the actual disease. Live vaccines are chosen where there is a need to reduce the risk of infections in ducks, by providing very strong protection and lifelong immunity from particular viral diseases.
• Killed Vaccines-These types of vaccines consist of dead or inactive viruses which trigger a much more mild immune response in ducks. They are obviously quite safe to use when compared with live vaccines, however there is more risk of contracting the virus at a later stage in life since they are not that effective. Usually, these killed vaccines are used with a combination of other medicines or vaccines in order to make sure they have an effective impact on the ducks.

By Application

• Duck-The main purpose of duck virus enteritis vaccines is to treat or prevent H5N1 avian influenza virus in ducks. The application of this vaccine is very important in order to offer protection to large populations of ducks, so that major farming operations are not negatively affected and the health of ducks is also kept at the forefront of such operations.
• Others-This category includes other miscellaneous waterfowl species who are susceptible to catching any form of avian viruses. It makes sense to provide the virus enteritis vaccine to a large variety of ducks and other species in order to avoid the cross-species spread of virus and protect all types of animal and bird populations from deadly diseases.

DRIVING FACTORS

"Heavy Global Consumption of Poultry Products"

The duck virus enteritis vaccine market growth has a significant positive growth across various nations in the world. In order to meet the rising demand of consumers of poultry products, it is becoming highly imperative to vaccinate large duck populations in order to prevent disease outbreaks and ensure that high quality products are delivered to commercial sectors.

"Technologically Advanced Vaccine Developments"

Vaccines which have been developed using new and advanced technologies by pharmaceutical and medical institutions is a vital factor propelling the market growth forward in forecasted years. The effectiveness and safety of such vaccines is being enhanced by using new vaccine formulations and exploring different delivery systems and techniques. These vaccine advancements help in reducing risks which are usually associated with vaccinations, while improving the rate of disease prevention through awareness and effective supply.

RESTRAINING FACTORS

"Strict Government Rules and Regulations"

The strict regulatory requirements which are imposed by governments in all nations who provide poultry products in a commercial aspect, make it very difficult for vaccine manufacturers to roll out these medications rapidly. Due to the requirement of stringent approvals, which are procured only after careful testing in stages, animal vaccine trials and finally cleared of any legal or ethical issues, it takes a very long amount of time as well as money to develop a vaccine which is approved to be circulated in markets.

DUCK VIRUS ENTERITIS VACCINE MARKET REGIONAL INSIGHTS

• 

   Request a Free Sample To Get Analysis on Major Geographic Market

The market is primarily segregated into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

"Asia-Pacific Dominating the Market due to High Poultry Consumption"

The Asia-Pacific market is heavily fueled by the huge poultry farming sectors in countries such as China, India, Japan and even South Korea. This is due to a strong and consistent demand of poultry products by consumers, and therefore increased need for DVE vaccines by pharmacies and medical institutions. Government initiatives to prevent such disease outbreaks are also major contributors towards the growth of this market.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Research and Development"

Major players in the industry are investing hugely in research and development initiatives to create safer, advanced and much more effective vaccines. The growing demand of pharmacies and consumers, coupled with stringent government regulations encourage these companies to come up with more effective vaccines.

List of Market Players Profiled

• Ceva Santé Animale (France)
• Chengdu TECBOND Biological (China)
• Institute of Animal Health and Veterinary Biologicals (India)
• Institute of Veterinary Preventive Medicine (India)
• International Duck Research Cooperative (US)
• MSD Animal Health (Merck) (US)
• Ringpu (Tianjin) Bio-Pharmacy (China)
• Veterinary Research Institute (Malaysia)

INDUSTRIAL DEVELOPMENT

March, 2024:A new vaccine developed and propagated by MSD Animal Health in order to support existing vaccination processes and improve the rate of disease prevention and overall health protection of waterfowl which are part of the global poultry industry.

REPORT COVERAGE

The report provides a comprehensive analysis of the global market for vaccines against duck virus enteritis, including market projections in the forecast period, a competitive landscape analysis based on various geographical regions, as well as detailed market segmentation according to application and type of vaccines.

In an effort to support vaccine producers and other major players involved in the duck virus enteritis market share, the growth potential as well as varied market dynamics is discussed at length. In order to supplement wise business and stakeholder decisions, the report conducts a detailed analysis, which provides further insights into the ongoing market trends, industry developments, opportunities, and limitations. Understanding these market dynamics ultimately helps in designing and creating strategies that will be beneficial during the forecast period.